NIRSEVIMAB

UNII: VRN8S9CW5V
Preferred Substance Name: NIRSEVIMAB

1989556-22-0
BEYFORTUS
IMMUNOGLOBULIN G1, ANTI-(HUMAN RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN)(HUMAN MONOCLONAL MED18897 .GAMMA.1-CHAIN), DISULFIDE WITH MONOCLONAL MED18897 .KAPPA.-CHAIN, DIMER
MED-18897
MEDI8897
NIRSEVIMAB [INN]
NIRSEVIMAB [JAN]
NIRSEVIMAB [USAN]
NIRSEVIMAB [WHO-DD]
NIRSEVIMAB-ALIP

Common Chemistry
i
Inxight Drugs
i
DailyMed Regulated Products
i
NCATS GSRS Full Record
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

NIRSEVIMAB

Synonyms and Mappings

Resources

Note